Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database
Kim YA, Cho H, Lee N, Jung SY, Sim SH, Park IH, Lee S, Lee ES, Kim HJ
Cancer Med. 2018 Dec;7(12):6084-6092
CARDIONCOLOGY.ORG ABSTRACT:
In this study data from 58 541 Korean cancer patients who received doxorubicin between 2003 and 2010 were analyzed to investigate the incidence and risk factors for doxorubicin-induced heart failure (HF).
Results indicated that management of risk factors, early detection, and treatment for doxorubicin-induced HF might be critical for patient survival.
© All Rights Reserved
Image source: https://www.superinformati.com/tumori/doxorubicina-nanoparticelle-cancro-al-seno.htm